generics
-
News
IQVIA report: thanks to biosimilars in the next 5 years average healthcare savings of almost 60 million euros per year
Milano, 3 luglio 2018 – Secondo lo studio di IQVIA «Farmaci biologici e biosimilari: scenari terapeutici e stima del risparmio per…
Leggi » -
News
Sanofi sells Zentiva: agreement with Advent for 1.9 billion euros
L’azienda francese cede il business dei generici alla società di private equity statunitense. La chiusura definitiva dell’operazione attesa nel quarto…
Leggi » -
News
AIFA clarifies on therapeutic equivalence. In no case can AIFA replace the doctor
Biosimilari, equivalenza terapeutica e libertà di scelta del medico. Per AIFA il lavoro quotidiano è dare risposta ai pazienti AIFA…
Leggi » -
News
Medicines, the Regions can lower the prices after the award of the tenders
giovedì 7 giugno 2018 Saitta: “il governo applichi questo criterio a livello nazionale: pronto a incontrare il nuovo ministro della…
Leggi » -
First floor
Therapeutic equivalence between different active ingredients. Even Radiologists say NO
Equivalenza terapeutica: i medici dicono no 07/06/2018 – Federfarma A contestare la delibera Aifa sull’equivalenza terapeutica sono, adesso, anche i…
Leggi » -
News
SNAMI. NO to therapeutic equivalence of drugs. Not everything is allowed in the name of savings
Roma, 5 Giugno 2018-Critiche pesanti del sindacato Snami all’emanazione da parte dell’AIFA dei criteri per determinare l’equivalenza terapeutica tra due…
Leggi » -
News
Rheumatic patients association. Biosimilars yes, but the patient's health must come before the budget
Biosimilars in rheumatic patients: Anmar's position The National Association of Rheumatic Patients anticipates the contents of a position paper which…
Leggi » -
News
Astrazeneca pays for the advance of generics
The collapse of profits ballast Astrazeneca, which fell sharply on the London Stock Exchange with -2.71% to 5.2 euros. There…
Leggi » -
News
The Chinese pharmaceutical market ranks second in the world after the United States
According to data recently collected by the health information company IQVIA, China has reached the second position as the…
Leggi » -
News
generics. Veneto TAR agrees with the Region "for technical reasons"
REJECTED BY VENETO TAR APPEAL AGAINST VENETO REGION AND ZERO COMPANY FOR AWARD OF EQUIVALENT DRUG FOR HIV TREATMENT "The failure…
Leggi »